Clinical trial
Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma
NCT03307395 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2017
- Completion date
- July 30, 2018
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic subdural hematoma